Skip to main content
logo
Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
3.410
+0.020 (0.59%)
At close: Sep 8, 2026, 4:00 PM EDT
3.437
+0.027 (0.79%)
After-hours: Sep 8, 2026, 4:52 PM EDT

Haoxi Health Technology Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
42.6832.848.5228.2316.1612.85
Revenue Growth
-12.85%-32.39%71.88%74.72%25.76%-
Cost of Revenue
40.6331.8845.7726.1715.5112.24
Gross Profit
2.040.932.752.060.650.61
Selling, General & Admin
9.522.850.950.810.280.21
Research & Development
0.070.080.080.060.10.06
Operating Expenses
9.62.931.030.870.380.28
Operating Income
-7.55-21.721.20.270.33
Interest Expense
-0.05-0.05-0.04-0.02-0.01-0
Interest & Investment Income
0.270.360.08---
Other Non Operating Income (Expenses)
5.835.83-0.020.020-0
Pretax Income
-2.44.151.741.190.260.33
Income Tax Expense
0.380.270.440.220.020.02
Net Income
-2.773.881.290.970.240.3
Net Income to Common
-2.773.881.290.970.240.3
Net Income Growth
-200.13%33.20%296.49%-19.56%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-3.37-3.36-0.8-0.92-0.682.65
Gross Margin
4.79%2.83%5.67%7.31%4.01%4.71%
Operating Margin
-17.70%-6.10%3.54%4.24%1.66%2.57%
Profit Margin
-6.49%11.82%2.66%3.44%1.51%2.37%
Free Cash Flow Margin
-7.90%-10.24%-1.65%-3.25%-4.23%20.59%
EBITDA
-7.05-1.711.731.20.270.33
EBITDA Margin
-16.52%-5.20%3.56%4.27%1.68%2.58%
D&A For EBITDA
0.50.290.010.0100
EBIT
-7.55-21.721.20.270.33
EBIT Margin
-17.70%-6.10%3.54%4.24%1.66%2.57%
Effective Tax Rate
-6.53%25.56%18.54%5.78%6.52%
SEC Filings: 10-K · 10-Q